Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Werewolf Therapeutics (HOWL)
NASDAQ:HOWL
Werewolf Therapeutics (HOWL) Stock Price & Analysis
124 Followers
HOWL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.57 - $8.19
Previous Close$5.87
Volume118.99K
Average Volume (3M)245.92K
Market Cap
$250.87M
Enterprise Value$173.00M
Total Cash (Recent Filing)$130.06M
Total Debt (Recent Filing)$52.19M
Price to Earnings (P/E)-5.6
Beta1.02
Next Earnings
May 08, 2024EPS Estimate
-$0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.05
Shares Outstanding42,737,191
10 Day Avg. Volume244,692
30 Day Avg. Volume245,923
Standard Deviation0.27
R-Squared0.02
Alpha-0.00032
Financial Highlights & Ratios
Price to Book (P/B)2.13
Price to Sales (P/S)299.26
Price to Cash Flow (P/CF)-8.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue26.03
Enterprise Value/Gross Profit207.43
Enterprise Value/Ebitda-5.32
Forecast
1Y Price Target
$13.67Price Target Upside132.88% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Werewolf Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HOWL FAQ
What was Werewolf Therapeutics’s price range in the past 12 months?
Werewolf Therapeutics lowest stock price was $1.57 and its highest was $8.19 in the past 12 months.
What is Werewolf Therapeutics’s market cap?
Currently, no data Available
When is Werewolf Therapeutics’s upcoming earnings report date?
Werewolf Therapeutics’s upcoming earnings report date is May 08, 2024 which is in 13 days.
How were Werewolf Therapeutics’s earnings last quarter?
Werewolf Therapeutics released its earnings results on Mar 07, 2024. The company reported -$0.33 earnings per share for the quarter, beating the consensus estimate of -$0.424 by $0.094.
Is Werewolf Therapeutics overvalued?
According to Wall Street analysts Werewolf Therapeutics’s price is currently Undervalued.
Does Werewolf Therapeutics pay dividends?
Werewolf Therapeutics does not currently pay dividends.
What is Werewolf Therapeutics’s EPS estimate?
Werewolf Therapeutics’s EPS estimate is -$0.34.
How many shares outstanding does Werewolf Therapeutics have?
Werewolf Therapeutics has 42,737,190 shares outstanding.
What happened to Werewolf Therapeutics’s price movement after its last earnings report?
Werewolf Therapeutics reported an EPS of -$0.33 in its last earnings report, beating expectations of -$0.424. Following the earnings report the stock price went down -3.983%.
Which hedge fund is a major shareholder of Werewolf Therapeutics?
Among the largest hedge funds holding Werewolf Therapeutics’s share is RA Capital Management. It holds Werewolf Therapeutics’s shares valued at 24M.
---
Werewolf Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.67 (132.88% Upside)
$13.67 (132.88% Upside)
Blogger Sentiment
Bullish
HOWL Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Positive
Last 7 Days ▼ 4.9%
Last 30 Days ▲ 9.1%
Last 30 Days ▲ 9.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
134.53%
12-Months-Change
Fundamentals
Return on Equity
-31.98%
Trailing 12-Months
Asset Growth
9.10%
Trailing 12-Months
Company Description
Werewolf Therapeutics
Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.
---
HOWL Stock 12 Months Forecast
Average Price Target
$13.67
▲(132.88% Upside)
Technical Analysis
Best Analysts Covering HOWL
1 Year
1 Year Success Rate
5/6 ratings generated profit
1 Year Average Return
+79.62%
reiterated a buy rating 6 months ago
Copying Jason Zemansky's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +79.62% per trade.
---